JDRF-funded clinical trial shows promise for suppressing the progression of Type 1 diabetes in those newly diagnosed
In December, JDRF Australia, a leading research funder of Type 1 diabetes announced a research breakthrough following a world-first Australian clinical trial which supressed Type 1 diabetes progression. The findings, which were published in the leading medical journal, The New England Journal of Medicine, detailed